2020-09-23
Animal models for COVID-19
Publication
Publication
Nature: international weekly journal of science , Volume 586 - Issue 7830 p. 509- 515
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the aetiological agent of coronavirus disease 2019 (COVID-19), an emerging respiratory infection caused by the introduction of a novel coronavirus into humans late in 2019 (first detected in Hubei province, China). As of 18 September 2020, SARS-CoV-2 has spread to 215 countries, has infected more than 30 million people and has caused more than 950,000 deaths. As humans do not have pre-existing immunity to SARS-CoV-2, there is an urgent need to develop therapeutic agents and vaccines to mitigate the current pandemic and to prevent the re-emergence of COVID-19. In February 2020, the World Health Organization (WHO) assembled an international panel to develop animal models for COVID-19 to accelerate the testing of vaccines and therapeutic agents. Here we summarize the findings to date and provides relevant information for preclinical testing of vaccine candidates and therapeutic agents for COVID-19
| Additional Metadata | |
|---|---|
| doi.org/10.1038/s41586-020-2787-6, hdl.handle.net/1765/131993 | |
| Nature: international weekly journal of science | |
| Organisation | Department of Internal Medicine |
|
Munoz-Fontela, C., Dowling, W.E., Funnell, S.G.P., Gsell, P.S., Riveros-Balta, A.X., Albrecht, R.A., … Barouch, D.H. (2020). Animal models for COVID-19. Nature: international weekly journal of science, 586(7830), 509–515. doi:10.1038/s41586-020-2787-6
|
|